CD8A and autoimmune disease: The expression of CD57 in both CD8+ T cells and NK cells has been previously shown to be a marker of terminal differentiation, and the frequency of cytotoxic CD57+ cells has been shown to increase with age and to expand in a number of autoimmune diseases as well as in cancer24.